QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 170 filers reported holding QIAGEN NV in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,095,000 | -17.8% | 74,763 | -19.5% | 0.22% | -31.7% |
Q3 2016 | $2,548,000 | +698.7% | 92,852 | +551.0% | 0.33% | +175.6% |
Q1 2016 | $319,000 | -35.7% | 14,264 | -34.6% | 0.12% | -6.3% |
Q3 2014 | $496,000 | +1.2% | 21,800 | -6.1% | 0.13% | -20.1% |
Q1 2014 | $490,000 | +7.2% | 23,214 | +20.9% | 0.16% | +84.9% |
Q4 2013 | $457,000 | +19.9% | 19,202 | +7.7% | 0.09% | +1.2% |
Q3 2013 | $381,000 | – | 17,827 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |